Catawba Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $1.23M | Buy |
35,030
+3,845
| +12% | +$135K | 0.29% | 79 |
|
|
2018
Q1 | $1.09M | Sell |
31,185
-180
| -0.6% | -$6.3K | 0.26% | 83 |
|
|
2017
Q4 | $1.09M | Hold |
31,365
| – | – | 0.25% | 86 |
|
|
2017
Q3 | $1.06M | Sell |
31,365
-440
| -1% | -$14.9K | 0.24% | 91 |
|
|
2017
Q2 | $1.08M | Buy |
31,805
+55
| +0.2% | +$1.88K | 0.25% | 91 |
|
|
2017
Q1 | $989K | Sell |
31,750
-5,040
| -14% | -$157K | 0.22% | 106 |
|
|
2016
Q4 | $1.01M | Sell |
36,790
-75
| -0.2% | -$2.05K | 0.23% | 106 |
|
|
2016
Q3 | $1.21M | Buy |
36,865
+1,125
| +3% | +$37K | 0.29% | 89 |
|
|
2016
Q2 | $1.08M | Hold |
35,740
| – | – | 0.26% | 95 |
|
|
2016
Q1 | $1.01M | Sell |
35,740
-2,800
| -7% | -$78.8K | 0.26% | 96 |
|
|
2015
Q4 | $1.31M | Sell |
38,540
-630
| -2% | -$21.4K | 0.36% | 76 |
|
|
2015
Q3 | $1.25M | Buy |
39,170
+4,860
| +14% | +$155K | 0.34% | 76 |
|
|
2015
Q2 | $1.09M | Hold |
34,310
| – | – | 0.26% | 91 |
|
|
2015
Q1 | $1.17M | Buy |
34,310
+850
| +3% | +$29.1K | 0.27% | 89 |
|
|
2014
Q4 | $1.18M | Sell |
33,460
-300
| -0.9% | -$10.6K | 0.27% | 90 |
|
|
2014
Q3 | $1.21M | Hold |
33,760
| – | – | 0.28% | 88 |
|
|
2014
Q2 | $1.25M | Sell |
33,760
-150
| -0.4% | -$5.57K | 0.28% | 91 |
|
|
2014
Q1 | $1.1M | Sell |
33,910
-4,260
| -11% | -$138K | 0.26% | 93 |
|
|
2013
Q4 | $1.13M | Buy |
38,170
+7,090
| +23% | +$210K | 0.27% | 90 |
|
|
2013
Q3 | $807K | Buy |
+31,080
| New | +$807K | 0.21% | 104 |
|